文献速递角膜与眼表疾病

MaR1 通过抑制 NLRP3/Caspase-1/GSDMD 介导的细胞焦亡改善蓝光过度暴露所致睑板腺功能障碍

Maresin 1 Ameliorates Blue Light Overexposure-Induced Meibomian Gland Dysfunction via Inhibition of NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2025-01-01

研究在大鼠蓝光暴露 1 个月诱导的睑板腺功能障碍模型及体外原代大鼠睑板腺上皮细胞焦亡模型中,观察 MaR1 的保护作用。结果显示蓝光暴露引起角膜荧光素染色、睑板腺导管阻塞及腺体总面积减少,伴 IL-1β、IL-18 上调和 NLRP3/caspase 1/GSDMD 介导的焦亡激活;MaR1 治疗后炎症细胞浸润减轻、脂质分泌功能恢复、导管角化受抑。

要点

  • 蓝光暴露 1 个月可诱导大鼠出现睑板腺功能障碍样表现及 NLRP3/caspase 1/GSDMD 焦亡激活。
  • MaR1 滴眼治疗减轻炎症细胞浸润、恢复睑板腺脂质分泌并抑制导管角化。
  • 体外实验中 MaR1 显著抑制原代大鼠睑板腺上皮细胞焦亡相关蛋白表达。

核心结论

  • MaR1 通过抑制 NLRP3/caspase 1/GSDMD 介导的细胞焦亡减轻蓝光诱导的睑板腺功能障碍,为环境相关干眼病提供新的治疗视角。

研究设计与样本

  • 体内实验:雄性 Sprague-Dawley 大鼠蓝光暴露 1 个月诱导睑板腺功能障碍,随后给予 MaR1 或 PBS 滴眼治疗 14 天。
  • 体外实验:脂多糖和 ATP 刺激原代大鼠睑板腺上皮细胞(PRMGECs)诱导焦亡模型,用免疫荧光和蛋白质印迹分析焦亡相关蛋白表达。

主要发现

  • 蓝光过度暴露诱导大鼠出现睑板腺功能障碍样临床体征,表现为广泛角膜荧光素染色、睑板腺导管阻塞及腺体总面积减少。
  • 上述眼表损伤伴 IL-1β 和 IL-18 水平上调及 NLRP3/caspase 1/GSDMD 介导的焦亡激活。
  • MaR1 治疗后炎症细胞浸润减轻、睑板腺脂质分泌功能恢复、导管过度角化受抑。
  • 体外实验中 MaR1 显著抑制 PRMGEC 焦亡模型中焦亡相关蛋白表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Blue light emitted from digital screens represents a significant environmental factor contributing to computer vision syndrome-related ocular surface damage. This study aimed to investigate the protective effects of maresin 1 (MaR1), a specialized proresolving lipid mediator derived from docosahexaenoic acid, in meibomian gland dysfunction (MGD) induced by blue light overexposure in both in vivo and in vitro experiments. METHODS: In vivo, male Sprague-Dawley rats were exposed to blue light for 1 month to induce MGD. After 14 days of MaR1 or PBS eye drop treatment, corneal fluorescein staining and inflammatory cytokine expression were evaluated. Lipid secretion and ductal keratinization were assessed using Nile red and keratin 1 staining. In vitro, pyroptosis was induced in primary rat meibomian gland epithelial cells (PRMGECs) by lipopolysaccharide and ATP stimulation, and pyroptosis-related protein expression was analyzed by immunofluorescence and Western blot analysis. RESULTS: Excessive blue light exposure induced MGD-like clinical signs, characterized by extensive corneal fluorescein staining, obstruction of MG ducts, and a reduction in total glandular area in rats. Moreover, these ocular surface injuries were accompanied by the upregulation of IL-1β and IL-18 levels and the activation of NLRP3/caspase 1/GSDMD-mediated pyroptosis. Following MaR1 treatment, inflammatory cell infiltration was alleviated, the lipid secretion function of the meibomian glands was restored, and ductal hyperkeratinization was suppressed. In vitro, MaR1 significantly inhibited pyroptosis-related protein expression in the PRMGEC pyroptosis model. CONCLUSIONS: Our study indicated that MaR1 alleviated blue light-induced MGD by inhibiting NLRP3/caspase 1/GSDMD-mediated pyroptosis. This finding provides a novel therapeutic perspective for the treatment of environment-related dry eye disease.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wu M, He HL, Wang C, et al. Maresin 1 Ameliorates Blue Light Overexposure-Induced Meibomian Gland Dysfunction via Inhibition of NLRP3/Caspase-1/GSDMD-Mediated Pyroptosis. Invest Ophthalmol Vis Sci. 2025. PMID: 41104959. doi:10.1167/iovs.66.13.29

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。